000			a
999			_c20759 _d20759
003			OSt
005			20240316103858.0
008			240316b xxu||||| |||| 00| 0 eng d
040			_aAIKTC-KRRC _cAIKTC-KRRC
100			_923028 _aAl-Zahrani
245			_aGenetic polymorphisms of GSTM1 and GPX1 genes and smoking susceptibility in the Saudi population
250			_aVol.15(4), Oct-Dec
260			_aMumbai _bACC LTD _c2023
300			_a180-189p.
520			_aAbstract Background/Objective/Methods: Glutathione-S-transferase Mu1 (GSTM1) and glutathione peroxidase 1 (GPX1) are known antioxidant enzymes that help protect cells from the oxidative damage that occurs from smoking. This study explored the correlation between GSTM1 and GPX1 levels between a group of smokers with the GSTM1 and GPX1 genes in the Saudi population and a control group and investigated the genetic risk factors in the group of smokers. Results: The control and smokers’ group (n = 50; aged 22.3 ± 3.1 years; BMI 24.6 ± 5.9 kg/m2) were genotyped using quantitative polymerase chain reaction (qPCR). In comparison with the control group, the smokers’ group displayed a different genotype disruption of GSTM1 and GPX1. Carriers of the homozygous (TT) genotype of GSTM1 had more than a twofold (OR = 2.71, 95% CI = 0.10–70.79, P = 1.000) smoking risk than the carriers of the heterozygous (CT) genotype. Those with the GPX1 gene showed no risk in the control and smokers’ groups. Smokers with the TT/GG combination (homozygous for GPX1 and normal for GPX1) were identified as high risk (OR = 2.58, 95% CI = 0.096–69.341). Conclusion: The main outcomes showed no significant association between genetic polymorphism of the GSTM1 and GPX1 genes and cigarette smoking in the Saudi Arabian population. However, the results showed a slight decrease in the number of GSTM1 and GPX1 gene modifications among smokers.
650		0	_94762 _aBIOCHEMISTRY
700			_923029 _aMaryam Hassan
773	0		_tJournal of pharmacy and bio allied science _x0976-4879
856			_uhttps://journals.lww.com/jpbs/fulltext/2023/15040/genetic_polymorphisms_of_gstm1_and_gpx1_genes_and.3.aspx _yClick here
942			_2ddc _cAR